Is my Estradiol (E2) normal?

What is a normal Estradiol level?

Estradiol is the primary estrogen hormone, essential for bone density, cardiovascular protection, brain function, and reproductive health. Optimal ranges are menstrual cycle phase-dependent for women: follicular 30-100 pg/mL, ovulatory 100-400 pg/mL, luteal 80-180 pg/mL, postmenopausal < 30 pg/mL. For men, maintaining estradiol between 20-40 pg/mL protects bone density and cardiovascular health without causing gynecomastia, water retention, or mood changes. Both extremes are problematic: low levels accelerate bone loss and cardiovascular risk, while excess estradiol in men (often from visceral fat aromatase activity) causes estrogenic side effects.

What causes abnormal Estradiol levels?

Low estradiol is caused by menopause, premature ovarian insufficiency, excessive exercise, very low body fat, eating disorders, pituitary dysfunction, and certain medications (aromatase inhibitors, GnRH agonists). High estradiol in women can indicate ovarian cysts, estrogen-producing tumors, or hormone replacement therapy. In men, high estradiol is typically caused by obesity (visceral fat aromatase converts testosterone to estradiol), liver disease, or exogenous testosterone therapy without aromatase management.

When should you see a doctor?

See your doctor if estradiol is below 30 pg/mL (premenopausal women) with symptoms like irregular periods, hot flashes, or bone loss. Men should consult if estradiol is above 40 pg/mL with symptoms like gynecomastia or low libido. Postmenopausal women considering hormone replacement therapy should discuss estradiol levels and cardiovascular risk-benefit with their doctor.

Estradiol and longevity

Estradiol is one of the most potent cardioprotective and neuroprotective hormones. The sharp decline in estradiol during menopause is a primary driver of accelerated cardiovascular disease risk, bone loss, and cognitive decline in women over 50. The Women's Health Initiative complicated hormone replacement therapy (HRT) messaging, but subsequent reanalysis shows that estradiol therapy initiated within 10 years of menopause (the "timing hypothesis") significantly reduces cardiovascular events and all-cause mortality. In men on testosterone replacement therapy, monitoring estradiol is essential — levels above 40-50 pg/mL may cause water retention, gynecomastia, and mood changes. Aromatase inhibitors are sometimes used but carry bone density risks. In premenopausal women, low estradiol relative to cycle phase may indicate ovarian insufficiency or hypothalamic amenorrhea. In men, the aromatase-obesity-estradiol axis creates a vicious cycle: visceral fat upregulates aromatase → testosterone converts to estradiol → estrogen promotes further fat storage → more aromatase activity. Body composition optimization is the primary intervention.

Where to get a Estradiol test

Affiliate disclosure: Some links on this page are affiliate links. Otto may earn a commission at no extra cost to you. This does not affect our recommendations.

Related biomarkers

These biomarkers are often tested alongside Estradiol for a more complete picture.

Frequently asked questions

More biomarker checkers